Plasma Fractionation Market Report 2024-2032 | Size, Share, Industry Trends, Growth and Opportunities

  2. by joeymoore
  3. May 8, 2024

The latest report by IMARC Group, titled “Plasma Fractionation Market Report by Product (Immunoglobulins, Albumin, Coagulation factor VIII, Coagulation factor IX), Sector (Private Sector, Public Sector), Application (Neurology, Immunology, Hematology, and Others), End User (Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the plasma fractionation market report.

Plasma Fractionation Market Size in 2024:

The global plasma fractionation market size reached US$ 25.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

  • ADMA Biologics
  • Bio Products Laboratory Ltd.
  • Boccard
  • Grifols
  • A.
  • Hemarus Therapeutics Limited
  • Intas Pharmaceuticals Limited
  • LFB S.A.
  • Merck Group
  • Octapharma AG
  • PlasmaGen BioSciences Pvt. Ltd.
  • SK Plasma Co. Ltd.
  • Virchow Biotech Private Limited

Factors Affecting the Growth of the Plasma Fractionation Industry:

  • Increasing Prevalence of Immunodeficiency Disorders: The global plasma fractionation market is primarily driven by the rising incidence of immunodeficiency disorders and other chronic conditions that necessitate plasma-derived therapies. Plasma fractionation, the process of separating various components of blood plasma, is crucial for producing essential proteins like immunoglobulins, which are vital for immune system function. With the growing awareness and diagnosis rates of immunodeficiency diseases, the demand for plasma products has increased. Additionally, the aging global population, which is more susceptible to such chronic diseases, further amplifies the need for plasma-derived therapeutics.
  • Technological Advancements in Fractionation Processes: Technological advancements in fractionation processes significantly contribute to the expansion of the global plasma fractionation market. Innovations in separation techniques and purification processes have enhanced the efficiency and yield of plasma products, making treatments more accessible and affordable. Modernization in the infrastructure of plasma collection and processing also plays a crucial role, enabling faster and safer production of plasma derivatives. These advancements ensure a higher quality of therapeutics as well as address the growing demand by optimizing production capacities.
  • Expanding Applications of Plasma-derived Products: The expanding applications of plasma-derived products in various medical treatments further drive the global plasma fractionation market. Beyond their traditional uses in treating immunodeficiencies and hemophilia, plasma products are now increasingly utilized in critical care and emergency medicine, including treatments for trauma, burns, and shock. The broadening scope of clinical applications, coupled with ongoing research and development activities, opens new avenues for plasma-derived therapies. This diversification in applications highlights the versatility of plasma products, fostering market growth by widening the consumer base and usage scenarios.

For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/plasma-fractionation-market/requestsample

Plasma Fractionation Market Report Segmentation:

Breakup by Product:

  • Immunoglobulins
  • Albumin
  • Coagulation factor VIII
  • Coagulation factor IX

On the basis of the product, the market has been divided into immunoglobulins, albumin, coagulation factor VIII, and coagulation factor IX.

Breakup by Sector:

  • Private Sector
  • Public Sector

Based on the sector, the market is bifurcated into the private and public sectors.

Breakup by Application:

  • Neurology
  • Immunology
  • Hematology
  • Other Applications

On the basis of the application, the market is divided into neurology, immunology, hematology, and other applications.

Breakup by End User:

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes

Based on the end user, the market is categorized into hospitals and clinics, clinical research laboratories, and academic institutes.

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Based on the region, the market includes North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.

Global Plasma Fractionation Market Trends:

In recent years, the global plasma fractionation market has witnessed an increasing investment in research and development aimed at discovering novel plasma-derived therapies and improving existing ones. This focus on innovation is driven by the need to enhance efficacy, reduce side effects, and expand the range of treatable conditions.

Furthermore, there is a growing emphasis on personalized medicine, where treatments are tailored to individual patient needs, potentially leading to more effective and targeted therapy options using plasma-derived products. Another significant opportunity lies in the expansion of plasma collection networks, especially in emerging economies.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=5973&flag=C

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163